| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
180,000
|
— | ₹0.49 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 3,600,000 |
100% | ₹9.72 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 180,000 | ₹0.49 |
5.00%
|
| Total | 3,600,000 | ₹9.72 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 8,000 | ₹216,000 |
| Retail (Max — 13 Lots) | 13 | 52,000 | ₹1,404,000 |
| S-HNI (Min — 14 Lots) | 14 | 56,000 | ₹1,512,000 |
| B-HNI (Min — 68 Lots) | 68 | 272,000 | ₹7,344,000 |
| Particulars | 10-Feb-22 | 31-Mar-21 | 31-Mar-20 |
|---|---|---|---|
| Revenue from Operations | 1056.58 | 1002.48 | 907.21 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 93.67 | 71.38 | 0.03 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 2660.58 | 804.63 | 565.22 |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Evoq Remedies Ltd. IPO is subscribed 1.00 times by Mar 22, 2022. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Evoq Remedies Ltd. IPO retail category is subscribed 1.00 times as of 22 Mar 2022. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 17 Mar 2022 and closes 22 Mar 2022. Min investment: ₹108,000 (1 lot = 4,000 shares). UPI mandate: 2022-03-22.
The Evoq Remedies Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (Bigshare Services Pvt.Ltd.) at https://ipo.bigshareonline.com/IPO_Status.html. Enter your PAN, application number or DP/Client ID. Allotment date: 25 Mar 2022. Refunds: on 28 Mar 2022.
The Evoq Remedies Ltd. IPO listing date is 30 Mar 2022, Wednesday. Listed on: BSE SME. Issue price: ₹27. Estimated listing: ₹27. GMP: NIL.
The Evoq Remedies Ltd. IPO closes on 22 Mar 2022, Tuesday. UPI mandate: 2022-03-22. Allotment: 25 Mar 2022. Listing: 30 Mar 2022.